Morgan Stanley analyst Simeon Gutman maintains Arhaus (NASDAQ:ARHS) with a Equal-Weight and raises the price target from $8 to $9.
Morgan Stanley Maintains Equal-Weight on Arhaus, Raises Price Target to $9
Morgan Stanley analyst Simeon Gutman maintains Arhaus (NASDAQ:ARHS) with a Equal-Weight and raises the price target from $8 to $9.
Related Posts
JP Morgan Downgrades Syneos Health to Underweight, Lowers Price Target to $28
JP Morgan analyst Casey Woodring downgrades Syneos Health (NASDAQ:SYNH) from Neutral to Underweight and lowers the price target from $30 to $28.
Earnings Scheduled For October 7, 2021
Companies Reporting Before The Bell
• Lamb Weston Hldgs (NYSE:LW) is estimated to report quarterly earnings at $0.39 per share on revenue of $993.09 million.
Tesla Recalls 3,470 Model Y Vehicles And A Software Update Won’t Resolve The Issue
Tesla, Inc. (NASDAQ: TSLA) announced a recall for its Model Y electric SUV.